1214336-90-9

Basic information

• Product Name: 2-Bromo-3-nitro-5-(trifluoromethyl)pyridine
• Synonyms: 2-Bromo-3-nitro-5-(trifluoromethyl)pyridine
• CAS NO: 1214336-90-9
• Molecular Formula: C₆H₂BrF₃N₂O₂
• Molecular Weight: 270.9914896
• Mol File: 1214336-90-9.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 243℃
• Flash Point: 101℃
• Appearance: /
• Density: 1.879
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -5.67±0.20(Predicted)
• CAS DataBase Reference: 2-Bromo-3-nitro-5-(trifluoromethyl)pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Bromo-3-nitro-5-(trifluoromethyl)pyridine(1214336-90-9)
• EPA Substance Registry System: 2-Bromo-3-nitro-5-(trifluoromethyl)pyridine(1214336-90-9)

Safety Data

• Hazardous Substances Data: 1214336-90-9(Hazardous Substances Data)

Usage

General Description

2-Bromo-3-nitro-5-(trifluoromethyl)pyridine is a chemical compound with the molecular formula C6H2BrF3N2O2. It is a derivative of pyridine and contains a bromine atom, a nitro group, and a trifluoromethyl group. 2-Bromo-3-nitro-5-(trifluoromethyl)pyridine is commonly used in the pharmaceutical and agrochemical industries as an intermediate for the synthesis of various chemical compounds. It has also been studied for its potential biological activities, such as its anti-inflammatory and anti-cancer properties. Additionally, it is considered to be a versatile building block for the synthesis of diverse chemical compounds due to its unique chemical structure and reactivity.

Upstream product

• 33252-64-1 3-nitro-5-trifluoromethylpyridin-2-ol 

Downstream Products

• 866775-16-8 3-nitro-5-trifluoromethyl-pyridine-2-carbonitrile 
• 866775-17-9 3-amino-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester 
• 866775-18-0 3-amino-6-bromo-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester 
• 1334546-83-6 3-amino-6-(2,4-dichlorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid 
• 1214370-77-0 3-amino-5-trifluoromethylpyridine-2-carboxylic acid 
• 1334547-21-5 3-amino-6-(4-fluorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid 
• 1334547-23-7 3-amino-6-(2,4-dichlorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid methyl ester 
• 1211515-30-8 3-amino-5-(trifluoromethyl)picolinonitrile 
• 1334546-80-3 3-amino-6-(4-fluorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid ((S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl)amide 
• 1427400-35-8 methyl 3-amino-6-(4-fluorophenyl)-5-(trifluoromethyl)picolinate 
• 1427400-25-6 3-amino-6-(4-fluorophenyl)-N-(1H-pyrazol-3-yl)-5-(trifluoromethyl)picolinamide 
• 1427262-80-3 (R)-2-(5-(amino(phenyl)methyl)-1,3,4-oxadiazol-2-yl)-6-bromo-5-(trifluoromethyl)pyridin-3-amine 
• 1427262-83-6 (R)-benzyl (5-(3-amino-6-bromo-5-(trifluoromethyl)pyridin-2-yl)-1,3,4-oxadiazol-2-yl)(phenyl)methylcarbamate 
• 1427262-81-4 (R)-benzyl 2-(2-(3-amino-6-bromo-5-(trifluoromethyl)picolinoyl)hydrazinyl)-2-oxo-1-phenylethylcarbamate 

Relevant articles and documents

Pyridine and Pyrazine derivative for the Treatment of CF, COPD, and Bronchiectasis

The present invention provides pyridine and pyrazine derivatives which restore or enhance the function of mutant and/or wild type CFTR to treat bronchiectasis, cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory tract infections, lung carcinoma, xerostomia and keratoconjunctivitis sire, or constipation (IBS, IBD, opioid induced). Pharmaceutical compositions comprising such derivatives are also encompassed.

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS

The present invention provides pyridin-oxadiazole/thiadiazole derivatives of Formula I wherein A is N or CR 4a; and (ii) or (iii) which restore or enhance the function of mutant and/or wild type CFTR to treat cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory tract infections, lung carcinoma, xerostomia and keratoconjunctivitis sire, or constipation (IBS, IBD, opioid induced). Pharmaceutical compositions comprising such derivatives are also encompassed.

Pyridine amide derivatives

The present invention provides pyridine amide derivatives which re? store or enhance the function of mutant and/or wild type CFTR to treat cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, resp